myeloma

Murakami et al. (1997) studied the effect of drugs treatments on levels of serum beta-2 microglobulin in patients with multiple myeloma. 
Serum beta-2 microglobulin is produced in the body as a result of myelomas, and thus can be used as an indicator of the severity of disease

datasets

Contains functions from: Aho, K. (2014) Foundational and Applied Statistics for Biologists using R.  CRC/Taylor and Francis, Boca Raton, FL, ISBN: 978-1-4398-7338-0.

Ken Aho

asbio

A Collection of Statistical Tools for Biologists

myeloma function

A data frame with 20 observations on the following 2 variables.<dl>
 <dt><code>mglobulin</code></dt>
<dd>Levels of serum beta-2 microglobulin in mg/l</dd> <dt><code>drug</code></dt>
<dd>Drug treatment strategy. <code>Control</code> = sumerifon alone, <code>Trt</code> = malphalan and sumerifon.</dd> 
</dl>

Format

Patient responses to myeloma drug treatments — myeloma

A data frame with 20 observations on the following 2 variables.<dl>
 <dt><code>mglobulin</code></dt>
<dd>Levels of serum beta-2 microglobulin in mg/l</dd>

 <dt><code>drug</code></dt>
<dd>Drug treatment strategy. <code>Control</code> = sumerifon alone, <code>Trt</code> = malphalan and sumerifon.</dd>

 
</dl>

myeloma: Patient responses to myeloma drug treatments

Description

Usage

Arguments

Format

References